Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease. (Q47977552)

7 February 2018

title

Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease. (English)

1 reference

7 February 2018

author name string

Monesha Gupta-Malhotra

1

1 reference

7 February 2018

Anne Viteri-Jackson

2

1 reference

7 February 2018

William Thomas

3

1 reference

7 February 2018

John B Zabriskie

4

1 reference

7 February 2018

publication date

1 April 2004

1 reference

7 February 2018

Experimental and Molecular Pathology

published in

1 reference

7 February 2018

volume

76

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

117-121

1 reference

7 February 2018

Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Structure and function of streptococcal and staphylococcal superantigens in septic shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Association of Toxic Shock Syndrome Toxin-Secreting and Exfoliative Toxin-Secreting Staphylococcus aureus with Kawasaki Syndrome Complicated by Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Transient low T cell response to streptococcal pyrogenic exotoxin-C in patients with Kawasaki disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Induction of protective immunity against experimental infection with malaria using synthetic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Agonist properties of a microbial superantigen peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Characterization and biological properties of a new staphylococcal exotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Increased levels of circulating soluble CD14 in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Selective increase of V beta 2+ T cells in the small intestinal mucosa in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Clinical aspects of 100 patients with Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Superantigenic exotoxin production by isolates of Staphylococcus aureus from the Kawasaki syndrome patients and age-matched control children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Immunologic cross-reactivity of type A streptococcal exotoxin (erythrogenic toxin) and staphylococcal enterotoxins B and C1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXMP.2003.12.003

1 reference

7 February 2018

PubMed ID

15010289

1 reference

7 February 2018